Atlas Trials

An Observational Study on Predicting the Efficacy of Immunotherapy for NSCLC Based on LIRAscore

Clinical trial NCT06232265 · UNKNOWN

Trial details

NCT number
NCT06232265
Sponsor
Nanfang Hospital, Southern Medical University
Status
UNKNOWN
Study type
OBSERVATIONAL
Non-small Cell Lung Cancer
Start date
2023-09-22
Primary completion
2025-08-01
Enrollment
108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.